Abstract
Angiogenesis is a hallmark of cancer and is important for tumor growth, development, and metastasis. Leukocytes, including neutrophils, eosinophils, basophils, lymphocytes, and monocytes, are found invading many solid tumors, and this inflammation is often associated with tumorigenesis. Tumor-associated macrophages have been shown to be involved in tumor migration and metastasis and are modulators of tumor vascularization. Tumor-associated macrophages are a source of angiogenic factors, and pro-inflammatory cytokines involved in angiogenesis, lymphangiogenesis, and metastasis. Here we describe a method of quantifying the number of macrophages and their class within tumor tissue which can be compared with tumor blood and lymphatic microvessel density as a measure of angiogenesis and lymphangiogenesis. Although not described in depth, application of the methodology is described for other leukocyte populations, such as tumor-infiltrating lymphocytes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ruegg C (2006) Leukocytes, inflammation, and angiogenesis in cancer: fatal attractions. J Leukoc Biol 80:682–684
Shih YY, Hsu YH, Duong TQ et al (2011) Longitudinal study of tumor-associated macrophages during tumor expansion using MRI. NMR Biomed 24:1353–1360
Ammar A, Mohammed RA, Salmi M et al (2011) Lymphatic expression of CLEVER-1 in breast cancer and its relationship with lymph node metastasis. Anal Cell Pathol (Amst) 34:67–78
Storr SJ, Safuan S, Mitra A et al (2012) Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma. Mod Pathol 25:493–504
Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605–612
Lewis JS, Landers RJ, Underwood JC et al (2000) Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J Pathol 192:150–158
Barbera-Guillem E, Nyhus JK, Wolford CC et al (2002) Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 62:7042–7049
Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676
Li C, Shintani S, Terakado N et al (2005) Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas. Int J Oral Maxillofac Surg 34:559–565
Cohen T, Nahari D, Cerem LW et al (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271:736–741
Fujimoto J, Aoki I, Khatun S et al (2002) Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers. Ann Oncol 13:430–434
Leibovich SJ, Polverini PJ, Shepard HM et al (1987) Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329:630–632
Wei LH, Kuo ML, Chen CA et al (2001) Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor. Gynecol Oncol 82:49–56
Medrek C, Ponten F, Jirstrom K et al (2012) The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 12:306
Shabo I, Stal O, Olsson H et al (2008) Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer 123:780–786
Webb JR, Milne K, Watson P et al (2014) Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Clin Cancer Res 20:434–444
Allavena P, Sica A, Solinas G et al (2008) The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 66:1–9
Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23–35
Ramprasad MP, Terpstra V, Kondratenko N et al (1996) Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc Natl Acad Sci U S A 93:14833–14838
Kunisch E, Fuhrmann R, Roth A et al (2004) Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry. Ann Rheum Dis 63:774–784
Schaer DJ, Schaer CA, Buehler PW et al (2006) CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. Blood 107:373–380
Edin S, Wikberg ML, Dahlin AM et al (2012) The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS One 7, e47045
Buechler C, Ritter M, Orso E et al (2000) Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 67:97–103
Leek RD, Lewis CE, Whitehouse R et al (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56:4625–4629
Vermeulen PB, Gasparini G, Fox SB et al (2002) Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 38:1564–1579
Tan KL, Scott DW, Hong F et al (2012) Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial. Blood 120:3280–3287
Berbic M, Schulke L, Markham R et al (2009) Macrophage expression in endometrium of women with and without endometriosis. Hum Reprod 24:325–332
Acknowledgments
The authors wish to acknowledge a grant from Breast Cancer Campaign (2011NovSP025) which funded this area of their research.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Ahmad, N.S., Martin, S.G., Storr, S.J. (2016). Immunohistochemical Assessment of Leukocyte Involvement in Angiogenesis. In: Martin, S., Hewett, P. (eds) Angiogenesis Protocols. Methods in Molecular Biology, vol 1430. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3628-1_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3628-1_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3626-7
Online ISBN: 978-1-4939-3628-1
eBook Packages: Springer Protocols